RICHARD HUBERMAN MD & ALAN J. POLLACK MD Revenue, Growth & Competitor Profile

DBA RICHARD HUBERMAN M.D. AND ALAN POLLACK, M.D., LTD.

Company Profile & Annual Report for Richard Huberman MD & Alan J. Pollack MD

Access the complete profile.

Richard Huberman MD & Alan J. Pollack MD Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	621112 Physicians, Mental Health Specialists
Additional NAICS Codes	621111
Address	4660 Kenmore Avenue, Suite 416 Alexandria, VA 22304

Note: Revenues for privately held companies are statistical evaluations.




Richard Huberman MD & Alan J. Pollack MD's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Richard Huberman MD & Alan J. Pollack MD Annual Revenue and Growth Rate

Richard Huberman MD & Alan J. Pollack MD	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Richard Huberman MD & Alan J. Pollack MD's revenues are gauged from an analysis of company filings.

Richard Huberman MD & Alan J. Pollack MD's Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Richard Huberman MD & Alan J. Pollack MD Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Recession Risk

Determine whether Richard Huberman MD & Alan J. Pollack MD grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Richard Huberman MD & Alan J. Pollack MD is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Richard Huberman MD & Alan J. Pollack MD's Largest Competitors

A competitive analysis shows these companies are in the same general field as Richard Huberman MD & Alan J. Pollack MD, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MAYO CLINIC AMBULANCE	Rochester, MN	100
SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP	Pasadena, CA	49
WEST VIRGINIA UNIVERSITY HOSPITALS	Morgantown, WV	39
PERMANENTE MEDICAL GROUP	Oakland, CA	37
MARSHFIELD CLINIC	Marshfield, WI	13
HEALTHCARE PARTNERS INSTITUTE FOR APPLIED RESEARCH & EDUCATION	El Segundo, CA	10
MHM SERVICES	Sterling, VA	7
MAGELLAN HEALTHCARE	Columbia, MD	5
ALTERNATIVE BEHAVIOR STRATEGIES	Salt Lake City, UT	5

Nearby Competitors

These companies are similar in business line and location to Richard Huberman MD & Alan J. Pollack MD. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NEIGHBORHOOD HEALTH	Alexandria, VA	100
PEDIATRIC ASSOCIATES OF ALEXANDRIA	Alexandria, VA	31
ALEXANDRIA-LAKE RIDGE PEDIATRICS	Alexandria, VA	28
CAPITAL HEALTHCARE PC	Alexandria, VA	23
CHILDREN'S MEDICAL ASSOCIATES OF NORTHERN VA P.C.	Alexandria, VA	21
POTOMAC UROLOGY	Alexandria, VA	20

Future Competition: Richard Huberman MD & Alan J. Pollack MD's Fastest Growing Competitors

These companies are in the same general field as Richard Huberman MD & Alan J. Pollack MD and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)